Emergent Biosolutions - Stock Price History | EBS

Historical daily share price chart and data for Emergent Biosolutions since 2020 adjusted for splits. The latest closing stock price for Emergent Biosolutions as of February 21, 2020 is 65.94.
  • The all-time high Emergent Biosolutions stock closing price was 73.24 on December 03, 2018.
  • The Emergent Biosolutions 52-week high stock price is 71.19, which is 8% above the current share price.
  • The Emergent Biosolutions 52-week low stock price is 39.11, which is 40.7% below the current share price.
  • The average Emergent Biosolutions stock price for the last 52 weeks is 51.22.
Emergent Biosolutions Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 51.8647 57.7000 66.1600 39.9200 53.9500 -8.99%
2018 56.2235 47.9700 73.2400 44.4400 59.2800 27.57%
2017 34.9138 33.2300 47.7500 28.3000 46.4700 41.50%
2016 33.3817 38.0900 44.2200 24.6000 32.8400 -17.92%
2015 31.9165 26.9000 40.2800 26.2300 40.0100 46.93%
2014 23.8045 24.0200 28.0900 19.9200 27.2300 18.44%
2013 17.2350 16.9000 23.9500 13.0800 22.9900 43.33%
2012 15.0918 17.0000 18.3400 12.9100 16.0400 -4.75%
2011 20.4083 23.7800 24.9800 15.0200 16.8400 -28.22%
2010 17.0443 13.8100 23.8000 13.4600 23.4600 72.63%
2009 15.8787 25.0900 26.2600 9.6200 13.5900 -47.95%
2008 12.3571 5.0900 26.1100 4.9900 26.1100 416.01%
2007 10.3642 11.3000 16.9800 4.7100 5.0600 -54.66%
2006 10.8245 11.7000 11.7000 9.7700 11.1600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.334B $1.106B
Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining the trust of their customers, employees and shareholders. The foundation of the corporate governance principles and practices are built on their reputation for openness, integrity and accountability. These are the principles that guide Emergent BioSolutions everyday. They have in place policies and practices to ensure that their Company is managed with integrity and in their shareholders' best interests. In addition, they are committed to meeting the requirements of federal and state law and the rules of the New York Stock Exchange.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.020B 14.98
CSL (CSLLY) Australia $101.716B 0.00
Gilead Sciences (GILD) United States $84.765B 10.91
Vertex Pharmaceuticals (VRTX) United States $63.547B 57.67
Biogen (BIIB) United States $58.597B 10.01
Illumina (ILMN) United States $44.168B 45.66
Regeneron Pharmaceuticals (REGN) United States $43.913B 18.60
Alexion Pharmaceuticals (ALXN) United States $22.702B 10.56
Seattle Genetics (SGEN) United States $20.383B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.943B 38.50
BioMarin Pharmaceutical (BMRN) United States $16.105B 0.00
Genmab (GNMSF) Denmark $15.176B 48.81
Alnylam Pharmaceuticals (ALNY) United States $14.987B 0.00
Galapagos (GLPG) Belgium $14.255B 36.73
Exact Sciences (EXAS) United States $13.326B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.443B 0.00
Sarepta Therapeutics (SRPT) United States $9.176B 0.00
QIAGEN (QGEN) Netherlands $8.414B 25.91
Guardant Health (GH) United States $8.209B 0.00
Bio-Techne Corp (TECH) United States $8.011B 54.82
BioNTech SE (BNTX) Germany $7.326B 0.00
Ascendis Pharma (ASND) Denmark $6.928B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.905B 0.00
Reata Pharmaceuticals (RETA) United States $6.773B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.750B 17.16
Exelixis (EXEL) United States $6.527B 18.36
Amarin (AMRN) Ireland $6.383B 0.00
Moderna (MRNA) United States $6.239B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.142B 0.00
Repligen (RGEN) United States $5.264B 96.31
Acceleron Pharma (XLRN) United States $5.035B 0.00
China Biologic Products (CBPO) China $4.598B 25.90
Bluebird Bio (BLUE) United States $4.584B 0.00
Adaptive Biotechnologies (ADPT) United States $4.203B 0.00
MorphoSys AG (MOR) Germany $3.896B 0.00
Mirati Therapeutics (MRTX) United States $3.706B 0.00
Blueprint Medicines (BPMC) United States $3.672B 0.00
Zai Lab (ZLAB) China $3.650B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.523B 0.00
Immunomedics (IMMU) United States $3.486B 0.00
NeoGenomics (NEO) United States $3.456B 183.89
CRISPR Therapeutics AG (CRSP) Switzerland $3.454B 58.51
Momenta Pharmaceuticals (MNTA) United States $3.363B 0.00
Alkermes (ALKS) Ireland $3.224B 255.38
Genmab (GMAB) Denmark $3.220B 12.63
Halozyme Therapeutics (HALO) United States $3.149B 0.00
MyoKardia (MYOK) United States $3.142B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.074B 0.00
UniQure (QURE) Netherlands $2.774B 0.00
Amicus Therapeutics (FOLD) United States $2.760B 0.00
Insmed (INSM) United States $2.719B 0.00
Arena Pharmaceuticals (ARNA) United States $2.667B 6.20
Denali Therapeutics (DNLI) United States $2.379B 0.00
Epizyme (EPZM) United States $2.321B 0.00
Principia Biopharma (PRNB) United States $2.290B 0.00
Fate Therapeutics (FATE) United States $2.219B 0.00
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Alector (ALEC) United States $2.059B 0.00
REGENXBIO (RGNX) United States $1.977B 0.00
Zymeworks (ZYME) Canada $1.829B 0.00
Ligand Pharmaceuticals (LGND) United States $1.780B 51.97
Akcea Therapeutics (AKCA) United States $1.732B 0.00
Arvinas (ARVN) United States $1.711B 0.00
Coherus BioSciences (CHRS) United States $1.578B 0.00
Myriad Genetics (MYGN) United States $1.483B 26.17
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Zealand Pharma (ZEAL) Denmark $1.474B 0.00
Zealand Pharma (ZLDPF) Denmark $1.461B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.404B 0.00
Intra-Cellular Therapies (ITCI) United States $1.361B 0.00
Editas Medicine (EDIT) United States $1.349B 0.00
Revance Therapeutics (RVNC) United States $1.244B 0.00
Athenex (ATNX) United States $1.193B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.187B 0.00
Twist Bioscience (TWST) United States $1.174B 0.00
PHARMA MAR SA (PHMMF) Spain $1.029B 0.00
Adverum Biotechnologies (ADVM) United States $1.017B 0.00
Mesoblast (MESO) Australia $0.931B 0.00
Cytokineticsorporated (CYTK) United States $0.915B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.874B 0.00
DBV Technologies S.A (DBVT) France $0.874B 0.00
Vericel (VCEL) United States $0.851B 317.17
Codexis (CDXS) United States $0.823B 0.00
Heska (HSKA) United States $0.805B 205.60
Cellectis S.A (CLLS) France $0.797B 0.00
Intrexon (PGEN) United States $0.768B 0.00
Retrophin (RTRX) United States $0.738B 0.00
ANI Pharmaceuticals (ANIP) United States $0.736B 12.56
Arcus Biosciences (RCUS) United States $0.731B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.716B 6.02
Cara Therapeutics (CARA) United States $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.688B 0.00
GENFIT S.A (GNFT) France $0.677B 0.00
Kadmon Holdings (KDMN) United States $0.655B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
UROGEN PHARMA (URGN) United States $0.632B 0.00
Cel-Sci (CVM) United States $0.620B 0.00
Bellus Health (BLU) Canada $0.601B 0.00
Anika Therapeutics (ANIK) United States $0.599B 20.49
Clovis Oncology (CLVS) United States $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.590B 0.00
NantKwest (NK) United States $0.586B 0.00
AC Immune SA (ACIU) Switzerland $0.568B 13.13
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Puma Biotechnology (PBYI) United States $0.544B 0.00
Compugen (CGEN) Israel $0.539B 0.00
Agenus (AGEN) United States $0.521B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
Prothena (PRTA) Ireland $0.477B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.473B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.449B 0.00
Sorrento Therapeutics (SRNE) United States $0.445B 0.00
Mersana Therapeutics (MRSN) United States $0.444B 0.00
AnaptysBio (ANAB) United States $0.435B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.432B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.423B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.414B 0.00
Dynavax Technologies (DVAX) United States $0.412B 0.00
Precision BioSciences (DTIL) United States $0.409B 0.00
Avid Bioservices (CDMO) United States $0.407B 0.00
Pfenex (PFNX) United States $0.407B 0.00
PDL BioPharma (PDLI) United States $0.396B 9.91
Gritstone Oncology (GRTS) United States $0.372B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Inovio Pharmaceuticals (INO) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.356B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 0.00
WAVE Life Sciences (WVE) Singapore $0.333B 0.00
Albireo Pharma (ALBO) United States $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.319B 0.00
OSMOTICA PHARM (OSMT) United States $0.313B 0.00
MannKind (MNKD) United States $0.312B 0.00
Aduro Biotech (ADRO) United States $0.312B 0.00
Syros Pharmaceuticals (SYRS) United States $0.311B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
Starpharma Holdings (SPHRY) Australia $0.302B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.297B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.276B 0.00
Kamada (KMDA) Israel $0.274B 11.39
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
VBI Vaccines (VBIV) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
IVERIC Bio (ISEE) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.264B 0.00
Geron (GERN) United States $0.256B 0.00
Novavax (NVAX) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.251B 0.00
Protagonist Therapeutics (PTGX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.243B 0.00
Kala Pharmaceuticals (KALA) United States $0.240B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Prometic Life Sciences (LMNL) Canada $0.228B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.225B 0.00
Alcobra (ARCT) United States $0.223B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.223B 11.46
Pieris Pharmaceuticals (PIRS) United States $0.216B 0.00
Arbutus Biopharma (ABUS) Canada $0.212B 0.00
Cerecor (CERC) United States $0.211B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.211B 0.00
Affimed (AFMD) Germany $0.209B 0.00
Theratechnologies (THTX) Canada $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
VolitionRX (VNRX) Singapore $0.205B 0.00
TELA Bio (TELA) United States $0.200B 0.00
Athersys (ATHX) United States $0.199B 0.00
Five Prime Therapeutics (FPRX) United States $0.195B 0.00
Fortress Biotech (FBIO) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 4.99
Spero Therapeutics (SPRO) United States $0.184B 0.00
Exicure (XCUR) United States $0.183B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Northwest Biotherapeutics (NWBO) United States $0.166B 0.00
CorMedix Inc (CRMD) United States $0.166B 0.00
Selecta Biosciences (SELB) United States $0.161B 0.00
Aptinyx (APTX) United States $0.160B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Verastem (VSTM) United States $0.156B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
Celyad SA (CYAD) Belgium $0.145B 0.00
ARAVIVE, INC (ARAV) United States $0.143B 0.00
Palatin Technologies (PTN) United States $0.141B 3.85
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
OvaScience (MLND) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Prima BioMed (IMMP) Australia $0.105B 0.00
Applied Genetic Technologies (AGTC) United States $0.104B 0.00
Proteostasis Therapeutics (PTI) United States $0.101B 0.00
Happiness Biotech Group (HAPP) China $0.100B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Emmaus Life Sciences (EMMA) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Synlogic (SYBX) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.084B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 5.05
Acorda Therapeutics (ACOR) United States $0.075B 0.00
Trevena (TRVN) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Soligenix (SNGX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.046B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Evogene (EVGN) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Celsion (CLSN) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
IBio (IBIO) United States $0.026B 0.00
VIVUS (VVUS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00